A G Protein-coupled Receptor Responsive to Bile Acids
Open accessThe DOI matches its Crossref record; 27 of the 27 references it cites were found in a registry or an index.
Abstract
So far some nuclear receptors for bile acids have been identified. However, no cell surface receptor for bile acids has yet been reported. We found that a novel G protein-coupled receptor, TGR5, is responsive to bile acids as a cell-surface receptor. Bile acids specifically induced receptor internalization, the activation of extracellular signal-regulated kinase mitogen-activated protein kinase, the increase of guanosine 5'-O-3-thio-triphosphate binding in membrane fractions, and intracellular cAMP production in Chinese hamster ovary cells expressing TGR5. Our quantitative analyses for TGR5 mRNA showed that it was abundantly expressed in monocytes/macrophages in human and rabbit. Treatment with bile acids was found to suppress the functions of rabbit alveolar macrophages including phagocytosis and lipopolysaccharide-stimulated cytokine productions. We prepared a monocytic cell line expressing TGR5 by transfecting a TGR5 cDNA into THP-1 cells that did not express TGR5 originally. Treatment with bile acids suppressed the cytokine productions in the THP-1 cells expressing TGR5, whereas it did not influence those in the original THP-1 cells, suggesting that TGR5 is implicated in the suppression of macrophage functions by bile acids.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Furthermore, KO of the BA receptors FXR (Nr1h4), TGR5 (Gpbar1), and VDR (Vdr) (36-38) did not rescue T cell function in LCA-fed mice (fig. S10, F and G).”
From Bile acid synthesis impedes tumor-specific T cell responses during liver cancer (2025) · cites this paper as [36]
In the citing paper
“activation of GPBAR1 on macrophages and Kupffer cells by synthetic agonists inhibits the expression of LPS-induced pro-inflammatory cytokines by interfering with NF-κB-dependent transcription.”
From Understanding the Holobiont: How Microbial Metabolites Affect Human Health and Shape the Immune System (2017) · cites this paper as Kawamata et al., 2003
In the citing paper
“Both receptors can be activated by primary and secondary bile acids alike (Kawamata et al., 2003; Makishima et al., 1999; Maruyama et al., 2002; Parks et al., 1999; H. Wang et al., 1999).”
From Understanding the Holobiont: How Microbial Metabolites Affect Human Health and Shape the Immune System (2017) · cites this paper as Kawamata et al., 2003
In the citing paper
“GPBAR1, as the name suggests, is a Gs-protein-coupled receptor. Binding by bile acids triggers an increase in intracellular cAMP levels and the activation of ERK (Kawamata et al., 2003; Maruyama et al., 2002).”
From Understanding the Holobiont: How Microbial Metabolites Affect Human Health and Shape the Immune System (2017) · cites this paper as Kawamata et al., 2003
In the citing paper
“This has been linked to direct inhibition of NF-κB activation, but is also consistent with a model of transcriptional competition between NF-κB and the cAMP-activated transcription factor cAMP response element binding protein (CREB) (C. Guo et al., 2015; Kawamata et al., 2003; Keitel et al., 2008; Pols et al., 2011; Y.-D. Wang et al., 2011; Wen et al., 2010).”
From Understanding the Holobiont: How Microbial Metabolites Affect Human Health and Shape the Immune System (2017) · cites this paper as Kawamata et al., 2003
6 more claims about this paper
Create a free account to see every claim other papers make about this one.
Citations
Cites
1 retracted
Sphingosylphosphorylcholine is a ligand for ovarian cancer G-protein-coupled receptor 1
Xu, Y., Zhu, K., Hong, G., Wu, W., Baudhuin, L. M., Xiao, Y.-J., & Damron, D. S. (2000) · Nature Cell Biology · doi:10.1038/35010529 · Cited by 289
RetractedCD14, a Receptor for Complexes of Lipopolysaccharide (LPS) and LPS Binding Protein
Wright, S. D., Ramos, R. A., Tobias, P. S., Ulevitch, R. J., & Mathison, J. C. (1990) · Science · doi:10.1126/science.1698311 · Cited by 3,987
Identification of a nuclear receptor for bile acids
Makishima, M., Okamoto, A. Y., Repa, J. J., Tu, H., Learned, R. M., Luk, A., Hull, M. V., Lustig, K. D., Mangelsdorf, D. J., & Shan, B. (1999) · Science · doi:10.1126/science.284.5418.1362 · Cited by 2,714
Bile Acids: Natural Ligands for an Orphan Nuclear Receptor
Parks, D. J., Blanchard, S. G., Bledsoe, R. K., Chandra, G., Consler, T. G., Kliewer, S. A., Stimmel, J. B., Willson, T. M., Zavacki, A. M., Moore, D. D., et al. (1999) · Science · doi:10.1126/science.284.5418.1365 · Cited by 2,274
SOSUI: classification and secondary structure prediction system for membrane proteins.
Hirokawa, T., Boon-Chieng, S., & Mitaku, S. (1998) · Bioinformatics · doi:10.1093/bioinformatics/14.4.378 · Cited by 1,936
An oxysterol signalling pathway mediated by the nuclear receptor LXRα
Janowski, B. A., Willy, P. J., Devi, T. R., Falck, J. R., & Mangelsdorf, D. J. (1996) · Nature · doi:10.1038/383728a0 · Cited by 1,591
The nuclear receptor PXR is a lithocholic acid sensor that protects against liver toxicity
Staudinger, J. L., Goodwin, B., Jones, S. A., Hawkins-Brown, D., MacKenzie, K. I., LaTour, A., Liu, Y., Klaassen, C. D., Brown, K. K., Reinhard, J., et al. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.051551698 · Cited by 1,379
A G-protein-coupled receptor for leukotriene B4 that mediates chemotaxis
Yokomizo, T., Izumi, T., Chang, K., Takuwa, Y., & Shimizu, T. (1997) · Nature · doi:10.1038/42506 · Cited by 971
Russell, D. W., & Setchell, K. D. R. (1992) · Biochemistry · doi:10.1021/bi00135a001 · Cited by 819
The Pregnane X Receptor: A Promiscuous Xenobiotic Receptor That Has Diverged during Evolution
Jones, S. A., Moore, L. B., Shenk, J. L., Wisely, G. B., Hamilton, G. A., McKee, D. D., Tomkinson, N. C. O., LeCluyse, E. L., Lambert, M. H., Willson, T. M., et al. (2000) · Molecular Endocrinology · doi:10.1210/me.14.1.27 · Cited by 672
Research works printed but not linked: 3
- Jones, 2000, Mol. Endocrinol., 14, 27, 10.1210/mend.14.1.0409 · doi:10.1210/mend.14.1.0409 · Paper page
- Keane, 1984, Surgery, 95, 439
- Kimmings, 1995, J. Am. Coll. Surg., 181, 567
Cited by
Items 301–400 of 1,002
Neuro-humoral signalling by bile acids and the TGR5 receptor in the gastrointestinal tract
Bunnett, N. W. (2014) · The Journal of Physiology · doi:10.1113/jphysiol.2014.271155 · Cited by 110
“and stimulation of protein kinase A (PKA; Maruyama et al. 2002; Kawamata et al. 2003).”
BackgroundInfluentialBile acid signaling and liver regeneration
Fan, M., Wang, X., Xu, G., Yan, Q., & Huang, W. (2015) · Biochimica et Biophysica Acta (BBA) - Gene Regulatory Mechanisms · doi:10.1016/j.bbagrm.2014.05.021 · Cited by 109
Shang, Q., Saumoy, M., Holst, J. J., Salen, G., & Xu, G. (2010) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00362.2009 · Cited by 110
Nutrient-Induced Cellular Mechanisms of Gut Hormone Secretion
Lu, V. B., Gribble, F. M., & Reimann, F. (2021) · Nutrients · doi:10.3390/nu13030883 · Cited by 117
“By contrast, FXR receptor activity inhibited GLP-1 production in L-cells [279], and the consequences of simultaneous activation of intestinal GPBAR1 and FXR receptors by bile acids still need to be reconciled.”
BackgroundInfluentialThe exercise-inducible bile acid receptor Tgr5 improves skeletal muscle function in mice
Sasaki, T., Kuboyama, A., Mita, M., Murata, S., Shimizu, M., Inoue, J., Mori, K., & Sato, R. (2018) · Journal of Biological Chemistry · doi:10.1074/jbc.ra118.002733 · Cited by 112
“Because TGR5 is coupled with G s, its activation enhances the cAMP– PKA–CREB pathway via adenylyl cyclase in various types of cells (2, 4, 30).”
BackgroundBerberine Directly Affects the Gut Microbiota to Promote Intestinal Farnesoid X Receptor Activation
Tian, Y., Cai, J., Gui, W., Nichols, R. G., Koo, I., Zhang, J., Anitha, M., & Patterson, A. D. (2019) · Drug Metabolism and Disposition · doi:10.1124/dmd.118.083691 · Cited by 106
“…to their well established role in regulating the metabolism of vitamins, lipids, and other hydrophobic dietary constituents, bile acids activate nuclear receptors and membrane G protein–coupled receptors to mediate lipid, glucose, and energy homeostasis (Kawamata et al., 2003; Li and Chiang, 2013).”
BackgroundLiu, T., Song, X., Khan, S., Li, Y., Guo, Z., Li, C., Wang, S., Dong, W., Liu, W., Wang, B., et al. (2019) · International Journal of Cancer · doi:10.1002/ijc.32563 · Cited by 109
“in the ileum and colon.(79) Among all bile acids, the microbiotainduced secondary bile acids LCA and DCA are the most potent GPBAR1 agonists, followed by CDCA and CA.”
BackgroundInfluentialThe microbiome: Composition and locations
Kennedy, M. S., & Chang, E. B. (2020) · Progress in molecular biology and translational science · doi:10.1016/bs.pmbts.2020.08.013 · Cited by 144
Cariello, M., Piccinin, E., & Moschetta, A. (2021) · Cellular and Molecular Gastroenterology and Hepatology · doi:10.1016/j.jcmgh.2021.01.012 · Cited by 120
Review article: therapeutic aspects of bile acid signalling in the gut‐liver axis
Simbrunner, B., Trauner, M., & Reiberger, T. (2021) · Alimentary Pharmacology & Therapeutics · doi:10.1111/apt.16602 · Cited by 114
Suga, T., Yamaguchi, H., Sato, T., Maekawa, M., Goto, J., & Mano, N. (2017) · PLOS ONE · doi:10.1371/journal.pone.0169719 · Cited by 101
“Individual bile acids display different potency in activating their nuclear receptors, including farnesoid X receptor (FXR) [6–8], pregnane X receptor [9], and vitamin D receptor [10], and cell surface receptors, including G protein-coupled receptor TGR5 [4, 11], sphingosine-1-phosphate receptor 2 (S1PR2) [12], and mu…”
BackgroundInfluentialIracheta‐Vellve, A., Calenda, C. D., Petrasek, J., Ambade, A., Kodys, K., Adorini, L., & Szabo, G. (2018) · Hepatology Communications · doi:10.1002/hep4.1256 · Cited by 103
“(34,46) TGR5 activation in macrophages by INT-777 potently inhibits inflammation by targeting cAMP- and nuclear factor (NF) kB signaling,(47) and bile acids inhibit LPS-induced proinflammatory cytokine expression in macrophages(46) and in Kupffer cells(34) through TGR5-cAMP-dependent pathways.”
BackgroundBile acids affect intestinal barrier function through FXR and TGR5
Song, G., Xie, Y., Yi, L., Cheng, W., Jia, H., Shi, W., Liu, Q., Fang, L., Xue, S., Liu, D., et al. (2025) · Frontiers in Medicine · doi:10.3389/fmed.2025.1607899 · Cited by 134
“This cascade initiates downstream signaling pathways, while cAMP production also influences energy and glucose metabolism (48).”
Role of TGR5 (GPBAR1) in Liver Disease
Häussinger, D., & Keitel, V. (2018) · Seminars in Liver Disease · doi:10.1055/s-0038-1669940 · Cited by 106
Chemoproteomic Profiling of Bile Acid Interacting Proteins
Zhuang, S., Li, Q., Cai, L., Wang, C., & Lei, X. (2017) · ACS Central Science · doi:10.1021/acscentsci.7b00134 · Cited by 115
Xiao, H., Sun, X., Liu, R., Chen, Z., Lin, Z., Yang, Y., Zhang, M., Liu, P., Quan, S., & Huang, H. (2019) · Pharmacological Research · doi:10.1016/j.phrs.2019.104559 · Cited by 110
Tokuhara, D. (2021) · Frontiers in Nutrition · doi:10.3389/fnut.2021.700058 · Cited by 112
“G-protein-coupled bile acid receptor (105) (Figure 3).”
Bile acids induce apoptosis selectively in androgen-dependent and -independent prostate cancer cells
Goldberg, A. A., Titorenko, V. I., Beach, A., & Sanderson, J. T. (2013) · PeerJ · doi:10.7717/peerj.122 · Cited by 106
Critical roles of bile acids in regulating intestinal mucosal immune responses
Sun, R., Xu, C., Feng, B., Gao, X., & Liu, Z. (2021) · Therapeutic Advances in Gastroenterology · doi:10.1177/17562848211018098 · Cited by 118
Pellicciari, R., Sato, H., Gioiello, A., Costantino, G., Macchiarulo, A., Sadeghpour, B. M., Giorgi, G., Schoonjans, K., & Auwerx, J. (2007) · Journal of Medicinal Chemistry · doi:10.1021/jm070633p · Cited by 103
Bile Acid Malabsorption in Inflammatory Bowel Disease
Vítek, L. (2015) · Inflammatory Bowel Diseases · doi:10.1097/mib.0000000000000193 · Cited by 99
Zarrinpar, A., & Loomba, R. (2012) · Alimentary Pharmacology & Therapeutics · doi:10.1111/apt.12084 · Cited by 103
Bile acid homeostasis in female mice deficient in Cyp7a1 and Cyp27a1
Rizzolo, D., Kong, B., Taylor, R. E., Brinker, A., Goedken, M. J., Buckley, B., & Guo, G. L. (2021) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2021.05.023 · Cited by 112
Physiological Role of Bile Acids Modified by the Gut Microbiome
Kiriyama, Y., & Nochi, H. (2021) · Microorganisms · doi:10.3390/microorganisms10010068 · Cited by 112
“Additionally, UDCA is a weak activator of TGR5 [81,83].”
BackgroundBile acid diarrhoea and FGF19: new views on diagnosis, pathogenesis and therapy
Walters, J. R. F. (2014) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/nrgastro.2014.32 · Cited by 112
Interactions between bile salts, gut microbiota, and hepatic innate immunity
Schubert, K., Olde Damink, S. W. M., von Bergen, M., & Schaap, F. G. (2017) · Immunological Reviews · doi:10.1111/imr.12579 · Cited by 105
Bile acids activated receptors in inflammatory bowel disease
Biagioli, M., Marchianò, S., Carino, A., Di Giorgio, C., Santucci, L., Distrutti, E., & Fiorucci, S. (2021) · Cells · doi:10.3390/cells10061281 · Cited by 103
Inhibition of apical sodium-dependent bile acid transporter as a novel treatment for diabetes
Chen, L., Yao, X., Young, A., McNulty, J., Anderson, D., Liu, Y., Nystrom, C., Croom, D., Ross, S., Collins, J., et al. (2012) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00323.2011 · Cited by 100
“They act upon at least two receptors, the (intracellular) nuclear farnesoid X receptor (Fxr) (22) and the (cell surface) Tgr5 G protein-coupled receptor (also known as GPBAR1 and M-BAR) (18).”
BackgroundTissue-specific function of farnesoid X receptor in liver and intestine
Zhu, Y., Li, F., & Guo, G. L. (2011) · Pharmacological Research · doi:10.1016/j.phrs.2010.12.018 · Cited by 100
“Activation of TGR5 is critical in modulating thyroid hormone function and thermogenesis in the brown adipose Pharmacol Res.”
BackgroundGenome–microbiome interplay provides insight into the determinants of the human blood metabolome
Diener, C., Dai, C. L., Wilmanski, T., Baloni, P., Smith, B., Rappaport, N., Hood, L., Magis, A. T., & Gibbons, S. M. (2022) · Nature Metabolism · doi:10.1038/s42255-022-00670-1 · Cited by 102
Jørgensen, N. B., Dirksen, C., Bojsen-Møller, K. N., Kristiansen, V. B., Wulff, B. S., Rainteau, D., Humbert, L., Rehfeld, J. F., Holst, J. J., Madsbad, S., et al. (2015) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2014-1658 · Cited by 101
“23 12 [8–13] 10 [9–14] 10 [8–11] 15 [12–21]* 0.”
Ishizawa, M., Matsunawa, M., Adachi, R., Uno, S., Ikeda, K., Masuno, H., Shimizu, M., Iwasaki, K., Yamada, S., & Makishima, M. (2008) · Journal of Lipid Research · doi:10.1194/jlr.m700293-jlr200 · Cited by 112
“Recently, the G protein-coupled receptor GPBAR1 was identified as a membrane receptor for bile acids (16, 21).”
BackgroundNew therapeutic approaches for the treatment of obesity
Saltiel, A. R. (2016) · Science Translational Medicine · doi:10.1126/scitranslmed.aad1811 · Cited by 102
“Primary bile acids are preferential ligands for the farnesoid X receptor (FXR), whereas secondary bile acids from the microbiota are ligands for G protein–coupled bile acid receptor 1 (GPBAR1), also known as TGR5 (162, 163).”
BackgroundChiang, J. Y. L., Pathak, P., Liu, H., Donepudi, A., Ferrell, J., & Boehme, S. (2017) · Digestive Diseases · doi:10.1159/000450981 · Cited by 97
Versatile Triad Alliance: Bile Acid, Taurine and Microbiota
Duszka, K. (2022) · Cells · doi:10.3390/cells11152337 · Cited by 110
“It recognizes both conjugated and free BAs with a preference for LCA > DCA > CDCA > CA [177].”
BackgroundUnlocking gut-liver-brain axis communication metabolites: energy metabolism, immunity and barriers
Sun, X., Shukla, M., Wang, W., & Li, S. (2024) · npj Biofilms and Microbiomes · doi:10.1038/s41522-024-00610-9 · Cited by 117
“ThemetabolismofBAsinthegut-liveraxisisprimarilyregulatedbytwokey receptors:TGR5andFXR.”
InfluentialDesai, M. S., Shabier, Z., Taylor, M., Lam, F., Thevananther, S., Kosters, A., & Karpen, S. J. (2010) · Hepatology · doi:10.1002/hep.23585 · Cited by 101
“7E), at concentrations capable of activating TGR5.”
BackgroundInfluentialMamic, P., Chaikijurajai, T., & Tang, W. H. W. (2020) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2020.12.001 · Cited by 106
“Several BA receptors, including farnesoid X receptor, GPCR TGR5, and muscarinic M2 receptor, are expressed on cardiomyocytes, through which BAs exert differential chronotropic, inotropic and lusitropic effects [78-84].”
BackgroundBile acid modulators for the treatment of nonalcoholic steatohepatitis (NASH)
Fiorucci, S., Biagioli, M., Sepe, V., Zampella, A., & Distrutti, E. (2020) · Expert Opinion on Investigational Drugs · doi:10.1080/13543784.2020.1763302 · Cited by 104
“The two best characterized BARs are the Farnesoid-x-receptors (FXR), discovered in 1995 and de-orphaned in 1999 as a nuclear transcription factor activated by primary bile acids [16–18] and the G Protein Bile Acid Receptor (GPBAR)-1, also known as TGR5, a seven-transmembrane G-protein coupled receptor discovered in 20…”
BackgroundLi, Z., Huang, J., Wang, F., Li, W., Wu, X., Zhao, C., Zhao, J., Wei, H., Wu, Z., Qian, M., et al. (2019) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.3652 · Cited by 98
Bile Acid-Activated Receptors: GPBAR1 (TGR5) and Other G Protein-Coupled Receptors
Keitel, V., Stindt, J., & Häussinger, D. (2019) · Handbook of Experimental Pharmacology · doi:10.1007/164_2019_230 · Cited by 98
Högenauer, K., Arista, L., Schmiedeberg, N., Werner, G., Jaksche, H., Bouhelal, R., Nguyen, D. G., Bhat, B. G., Raad, L., Rauld, C., et al. (2014) · Journal of Medicinal Chemistry · doi:10.1021/jm501052c · Cited by 95
Molecular features of bile salt hydrolases and relevance in human health
Chand, D., Avinash, V. S., Yadav, Y., Pundle, A. V., Suresh, C. G., & Ramasamy, S. (2016) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/j.bbagen.2016.09.024 · Cited by 107
Bile acids: From digestion to cancers
Baptissart, M., Vega, A., Maqdasy, S., Caira, F., Baron, S., Lobaccaro, J.-M. A., & Volle, D. H. (2013) · Biochimie · doi:10.1016/j.biochi.2012.06.022 · Cited by 97
“In human colon cancer cell line (H508 cells), taurine and glycine conjugates of LCA and DCA induce cell proliferation through the M3 muscarinic receptor-dependent pathway and transactivation of epidermal growth factor receptor (EGFR) [132].”
BackgroundBile Acid Sequestrants for Lipid and Glucose Control
Staels, B., Handelsman, Y., & Fonseca, V. A. (2010) · Current Diabetes Reports · doi:10.1007/s11892-009-0087-5 · Cited by 108
“TGR5 is activated by multiple bile acids, with lithocholic acid being the most potent natural agonist (EC50 of 530 nM) [18].”
BackgroundSpinelli, V., Lalloyer, F., Baud, G., Osto, E., Kouach, M., Daoudi, M., Vallez, E., Raverdy, V., Goossens, J.-F., Descat, A., et al. (2016) · International Journal of Obesity · doi:10.1038/ijo.2016.46 · Cited by 101
Melhem, H., Kaya, B., Ayata, C. K., Hruz, P. L., & Niess, J. H. (2019) · Cells · doi:10.3390/cells8050450 · Cited by 102
“This receptor is particularly relevant for gut macrophages and monocytes because it can recognize primary and secondary bile acid metabolites [134].”
BackgroundD’Amore, C., Leva, F. S. D., Sepe, V., Renga, B., Gaudio, C. D., D’Auria, M. V., Zampella, A., Fiorucci, S., & Limongelli, V. (2014) · Journal of Medicinal Chemistry · doi:10.1021/jm401873d · Cited by 99
Human Gut Microbiota in Health and Alzheimer’s Disease
Szablewski, L. (2018) · Journal of Alzheimer’s Disease · doi:10.3233/jad-170908 · Cited by 91
“Gut microbiota also releases agonists that regulate TGR5 signaling [82].”
Guo, C., Qi, H., Yu, Y., Zhang, Q., Su, J., Yu, D., Huang, W., Chen, W.-D., & Wang, Y.-D. (2015) · Frontiers in Pharmacology · doi:10.3389/fphar.2015.00287 · Cited by 95
Bile Acid Receptors and the Gut–Liver Axis in Nonalcoholic Fatty Liver Disease
Xue, R., Su, L., Lai, S., Wang, Y., Zhao, D., Fan, J., Chen, W., Hylemon, P. B., & Zhou, H. (2021) · Cells · doi:10.3390/cells10112806 · Cited by 95
“Taurine conjugation of LCA and DCA further enhanced their TGR5 agonistic activity, rendering TLCA and TDCA the most potent TGR5 agonists [52].”
BackgroundHansen, M., Scheltema, M. J., Sonne, D. P., Hansen, J. S., Sperling, M., Rehfeld, J. F., Holst, J. J., Vilsbøll, T., & Knop, F. K. (2016) · Diabetes, Obesity and Metabolism · doi:10.1111/dom.12648 · Cited by 96
“Furthermore, while CDCA is the most abundant bile acid in humans, it is only a moderately potent TGR5 agonist [30].”
BackgroundPostprandial plasma bile acid responses in normal weight and obese subjects
Glicksman, C., Pournaras, D. J., Wright, M., Roberts, R., Mahon, D., Welbourn, R., Sherwood, R., Alaghband-Zadeh, J., & le Roux, C. W. (2010) · Annals of Clinical Biochemistry International Journal of Laboratory Medicine · doi:10.1258/acb.2010.010040 · Cited by 94
TGR5 Signaling in Hepatic Metabolic Health
Holter, M. M., Chirikjian, M. K., Govani, V. N., & Cummings, B. P. (2020) · Nutrients · doi:10.3390/nu12092598 · Cited by 88
“TGR5 is expressed in endocrine glands, the kidney, adipocytes, muscle, the central nervous system, immune cells, spleen, lung, the gastrointestinal tract (mainly in the ileum and colon), and the enteric nervous system [1,2,36].”
BackgroundInfluentialPrimary sclerosing cholangitis
Silveira, M. G., & Lindor, K. D. (2008) · Canadian Journal of Gastroenterology · doi:10.1155/2008/824168 · Cited by 93
Expression of bile acid receptor TGR5 in gastric adenocarcinoma
Cao, W., Tian, W., Hong, J., Li, D., Tavares, R., Noble, L., Moss, S. F., & Resnick, M. B. (2013) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00263.2012 · Cited by 93
“Deoxycholic acid, TDCA, and glycodeoxycholic acid have similar strengths at inducing cAMP production (12).”
BackgroundInfluentialLiu, J., Lü, H., Lu, Y., Lei, X., Cui, J. Y., Ellis, E. C. S., Strom, S. C., & Klaassen, C. D. (2014) · Toxicological Sciences · doi:10.1093/toxsci/kfu151 · Cited by 103
Busnelli, M., Manzini, S., & Chiesa, G. (2019) · Nutrients · doi:10.3390/nu12010079 · Cited by 98
Tie, Y., Huang, Y., Chen, R., Li, L., Chen, M., & Zhang, S. (2023) · Gut Microbes · doi:10.1080/19490976.2023.2265028 · Cited by 97
“103 Bile acids act by inter-acting with transmembrane G protein-coupled receptor 5 (TGR5), farnesoid X receptor (FXR), etc. Notably, CDCA has the highest affinity for FXR, while SBAs have a high affinity for TGR5.”
BackgroundUllmer, C., Alvarez Sanchez, R., Sprecher, U., Raab, S., Mattei, P., Dehmlow, H., Sewing, S., Iglesias, A., Beauchamp, J., & Conde‐Knape, K. (2013) · British Journal of Pharmacology · doi:10.1111/bph.12158 · Cited by 92
“In accordance with several previous studies (Maruyama et al., 2002; Kawamata et al., 2003; Katsuma et al., 2005; Thomas et al., 2009), activation of GPBAR1 by RO5527239 and the BA DCA triggered a dose-dependent increase in intracellular cAMP levels in enteroendocrine STC-1 cells (Figure 3A).”
BackgroundResultDissecting the Physiology and Pathophysiology of Glucagon-Like Peptide-1
Paternoster, S., & Falasca, M. (2018) · Frontiers in Endocrinology · doi:10.3389/fendo.2018.00584 · Cited by 91
“distributed along the whole gastrointestinal tract of dogs (101, 272, 273).”
BackgroundFXR an emerging therapeutic target for the treatment of atherosclerosis
Mencarelli, A., & Fiorucci, S. (2010) · Journal of Cellular and Molecular Medicine · doi:10.1111/j.1582-4934.2009.00997.x · Cited by 91
Bile Acid Receptors and Liver Cancer
Wang, X., Fu, X., Van Ness, C., Meng, Z., Ma, X., & Huang, W. (2013) · Current Pathobiology Reports · doi:10.1007/s40139-012-0003-6 · Cited by 91
Advances in understanding of bile acid diarrhea
Camilleri, M. (2014) · Expert Review of Gastroenterology & Hepatology · doi:10.1586/17474124.2014.851599 · Cited by 93
Jensen, D. D., Godfrey, C. B., Niklas, C., Canals, M., Kocan, M., Poole, D. P., Murphy, J. E., Alemi, F., Cottrell, G. S., Korbmacher, C., et al. (2013) · Journal of Biological Chemistry · doi:10.1074/jbc.m113.455774 · Cited by 89
“TGR5 (GpBAR1 or M-BAR1) is a G proteincoupled receptor (GPCR) of the plasma membrane that interacts with multiple BAs that activate TGR5 with graded potencies (4, 9, 10).”
BackgroundResultInfluentialPeng, X.-R., Feng, L., Jiang, W., Wu, P., Liu, Y., Jiang, J., Kuang, S., Tang, L., & Zhou, X. (2019) · Fish & Shellfish Immunology · doi:10.1016/j.fsi.2019.06.047 · Cited by 95
Chen, Y., Le, T. H., Du, Q., Zhao, Z., Liu, Y., Zou, J., Hua, W., Liu, C., & Zhu, Y. (2019) · International Immunopharmacology · doi:10.1016/j.intimp.2019.01.021 · Cited by 92
Kriegermeier, A. A., & Green, R. R. (2020) · Frontiers in Medicine · doi:10.3389/fmed.2020.00149 · Cited by 97
“Secondary bile acids (LCA and DCA) are potent activators TGR5 (GPBAR1) (68, 69).”
BackgroundInfluentialGut microbiota and systemic immunity in health and disease
Lo, B. C., Chen, G., Núñez, G., & Caruso, R. (2020) · International Immunology · doi:10.1093/intimm/dxaa079 · Cited by 93
Alexander, S., Mathie, A. A., & Peters, J. (2011) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2011.01649_3.x · Cited by 93
Bile Acids, Their Receptors, and the Gut Microbiota
Poland, J. C., & Flynn, C. R. (2021) · Physiology · doi:10.1152/physiol.00028.2020 · Cited by 102
Discovery of Intestinal Targeted TGR5 Agonists for the Treatment of Type 2 Diabetes
Duan, H., Ning, M., Zou, Q., Ye, Y., Feng, Y., Zhang, L., Leng, Y., & Shen, J. (2015) · Journal of Medicinal Chemistry · doi:10.1021/jm500829b · Cited by 86
McIlvride, S., Dixon, P. H., & Williamson, C. (2017) · Molecular Aspects of Medicine · doi:10.1016/j.mam.2017.05.003 · Cited by 113
“However, as mentioned in Section 2.1, TGR5 has as higher affinity for the secondary bile acids LCA and DCA, than CA and CDCA (Kawamata et al., 2003), which are present at higher concentrations in pregnancy and ICP.”
BackgroundInfluentialÁbrigo, J., González, F., Aguirre, F. S., Tacchi, F., González, A., Meza, M. P., Simón, F., Cabrera, D., Arrese, M. A., Karpen, S. J., et al. (2020) · Journal of Cellular Physiology · doi:10.1002/jcp.29839 · Cited by 93
“These functions are dependent on the activation of two receptors for bile acids: intracellular farnesoid X receptor (FXR) and plasma membrane G‐protein‐coupled TGR5 receptor (Deutschmann et al., 2018; Kawamata et al., 2003; Keitel, Stindt, & Haussinger, 2019; Makishima et al., 1999).”
BackgroundVassileva, G., Hu, W., Hoos, L., Tetzloff, G., Yang, S., Liu, L., Kang, L., Davis, H. R., Hedrick, J. A., Lan, H., et al. (2010) · Journal of Endocrinology · doi:10.1677/joe-10-0009 · Cited by 82
“GPBAR1 is a Gs-coupled cell surface receptor that is expressed on the plasma membrane, and is internalized in response to agonist activation (Kawamata et al. 2003).”
BackgroundSignificance and Mechanism of CYP7a1 Gene Regulation during the Acute Phase of Liver Regeneration
Zhang, L., Huang, X., Meng, Z., Dong, B., Shiah, S., Moore, D. D., & Huang, W. (2009) · Molecular Endocrinology · doi:10.1210/me.2008-0198 · Cited by 89
“Bile acids can activate MAPK pathways (21, 22) and are ligands for the G-protein-coupled receptor TGR5 (23, 24).”
Liu, S., Marcelin, G., Blouet, C., Jeong, J. H., Jo, Y.-H., Schwartz, G. J., & Chua, S. (2018) · Molecular Metabolism · doi:10.1016/j.molmet.2017.12.003 · Cited by 90
“Alternatively, it is possible that both arms of bile acid signaling, via both FXR and TGR5/GPBAR1 concurrently, may be necessary for effective improvement in glucose handling. access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).”
BackgroundInfluentialLithocholic Acid Is an Eph-ephrin Ligand Interfering with Eph-kinase Activation
Giorgio, C., Hassan Mohamed, I., Flammini, L., Barocelli, E., Incerti, M., Lodola, A., & Tognolini, M. (2011) · PLoS ONE · doi:10.1371/journal.pone.0018128 · Cited by 83
“Other papers described specific interaction of bile acids with the nuclear farnesoid X receptor, mainly involved in hepatic lipid and glucose metabolism [22] and with the G protein coupled receptor TGR5 whereby they induce intracellular cAMP increase in CHO cells [23].”
BackgroundRajagopal, S., Kumar, D. P., Mahavadi, S., Bhattacharya, S., Zhou, R., Corvera, C. U., Bunnett, N. W., Grider, J. R., & Murthy, K. S. (2013) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00388.2012 · Cited by 81
“TGR5 expression is more abundant in liver, adipose tissue, and intestine compared with other tissues and is more selectively activated by LCA compared with other bile acids (8, 16).”
BackgroundDoignon, I., Julien, B., Serrière-Lanneau, V., Garcin, I., Alonso, G., Nicou, A., Monnet, F., Gigou, M., Humbert, L., Rainteau, D., et al. (2011) · Journal of Hepatology · doi:10.1016/j.jhep.2010.07.012 · Cited by 87
“Interestingly, bile acids have also been reported to signal through the membrane bound receptor GPBAR1 (or TGR5), expressed in numerous cell types and organs [6], although the functions of TGR5 signaling remain poorly defined [7].”
Bile acid-based therapies for non-alcoholic steatohepatitis and alcoholic liver disease
Li, T., & Chiang, J. Y. L. (2020) · HepatoBiliary Surgery and Nutrition · doi:10.21037/hbsn.2019.09.03 · Cited by 91
Berardo, C., Pasqua, L. G. D., Cagna, M., Richelmi, P., Vairetti, M., & Ferrigno, A. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21249646 · Cited by 98
Duan, H., Ning, M., Chen, X., Zou, Q., Zhang, L., Feng, Y., Zhang, L., Leng, Y., & Shen, J. (2012) · Journal of Medicinal Chemistry · doi:10.1021/jm301071h · Cited by 83
Immunology of bile acids regulated receptors
Fiorucci, S., Marchianò, S., Urbani, G., Giorgio, C. D., Distrutti, E., Zampella, A., & Biagioli, M. (2024) · Progress in Lipid Research · doi:10.1016/j.plipres.2024.101291 · Cited by 92
Stepanov, V., Stankov, K., & Mikov, M. (2013) · Journal of Receptors and Signal Transduction · doi:10.3109/10799893.2013.802805 · Cited by 83
“TGR5, also known as M-BAR, GPBAR, GPR131 or BG37, is a plasma membrane-bound receptor, discovered in 2002 (16) and characterized in more detail in 2003 (10).”
BackgroundBile acids and neurological disease
Hurley, M. J., Bates, R., Macnaughtan, J., & Schapira, A. H. V. (2022) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2022.108311 · Cited by 88
“Kawamata and colleagues (Kawamata et al., 2003) used qPCR to examine the tissue distribution of GPBAmRNA in human and rabbit tissue.”
BackgroundBile Acid Signaling in Metabolic and Inflammatory Diseases and Drug Development
Li, T., & Chiang, J. Y. L. (2024) · Pharmacological Reviews · doi:10.1124/pharmrev.124.000978 · Cited by 90
Bile acid sequestrants: more than simple resins
Out, C., Groen, A. K., & Brufau, G. (2012) · Current Opinion in Lipidology · doi:10.1097/mol.0b013e32834f0ef3 · Cited by 80
“The decrease in bile salt reabsorption caused by BAS treatment might increase the luminal concentration of bile salts which in turn would be able to activate TGR-5 [88,89].”
BackgroundInfluentialThe interrelationship between bile acid and vitamin A homeostasis
Saeed, A., Hoekstra, M., Hoeke, M. O., Heegsma, J., & Faber, K. N. (2017) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/j.bbalip.2017.01.007 · Cited by 96
Mechanism of glucose-lowering by metformin in type 2 diabetes: Role of bile acids
Sansome, D. J., Xie, C., Veedfald, S., Horowitz, M., Rayner, C. K., & Wu, T. (2020) · Diabetes, Obesity and Metabolism · doi:10.1111/dom.13869 · Cited by 84
Lund, M. L., Sorrentino, G., Egerod, K. L., Kroone, C., Mortensen, B., Knop, F. K., Reimann, F., Gribble, F. M., Drucker, D. J., de Koning, E. J. P., et al. (2020) · Diabetes · doi:10.2337/db19-0764 · Cited by 82
“Lithocholic acid (LCA) has the highest affinity to GPBAR1 among secondary bile acids (13).”
BackgroundKomatsu, H., Maruyama, M., Shuuhei, Y., Shinohara, T., Sakuma, K., Imaichi, S., Chikatsu, T., Kuniyeda, K., Siu, F. K., Peng, L. S., et al. (2014) · PLoS ONE · doi:10.1371/journal.pone.0090134 · Cited by 88
Self-citationGPBAR1/TGR5 Mediates Bile Acid-Induced Cytokine Expression in Murine Kupffer Cells
Lou, G., Ma, X., Fu, X., Meng, Z., Zhang, W., Wang, Y.-D., Van Ness, C., Yu, D., Xu, R., & Huang, W. (2014) · PLoS ONE · doi:10.1371/journal.pone.0093567 · Cited by 80
“Wild-type and TGR5 mice (n = 5/group) were fed with normal diet [1] or 1% CA diet for 3 days.”
BackgroundMethodLiver X Receptor α and Farnesoid X Receptor Are Major Transcriptional Regulators of OATP1B1
zu Schwabedissen, H. E. M., Böttcher, K., Chaudhry, A. S., Kroemer, H. K., Schuetz, E. G., & Kim, R. B. (2010) · Hepatology · doi:10.1002/hep.23876 · Cited by 84
“Introducing an additional factor to this network of OATP1B1 expression is the G protein–coupled receptor TGR5, which induces intracellular cAMP levels upon binding of bile acids.(33) Thus, increased bile acid levels would reduce the expression of both bile acid transporters through suppression of HNF4a activity and ex…”
BackgroundLewis, N. D., Patnaude, L. A., Pelletier, J., Souza, D. J., Lukas, S. M., King, F. J., Hill, J. D., Stefanopoulos, D. E., Ryan, K., Desai, S., et al. (2014) · PLoS ONE · doi:10.1371/journal.pone.0100883 · Cited by 84
“To understand the role of GPBAR1 in inflammation, we first confirmed that human monocytes express high levels of GPBAR1 as reported [10].”
BackgroundMethodInfluentialIbrahim, E., Diakonov, I. A., Arunthavarajah, D., Swift, T., Goodwin-Trotman, M., McIlvride, S., Nikolova, V., Williamson, C., & Gorelik, J. (2018) · Scientific Reports · doi:10.1038/s41598-018-25569-4 · Cited by 90
Brown adipose tissue: a potential target in the fight against obesity and the metabolic syndrome
Poekes, L., Lanthier, N., & Leclercq, I. A. (2015) · Clinical Science · doi:10.1042/cs20150339 · Cited by 80
Bile Acid Uptake Transporters as Targets for Therapy
Slijepcevic, D., & van de Graaf, S. F. J. (2017) · Digestive Diseases · doi:10.1159/000450983 · Cited by 87
Regulation of Adaptive Thermogenesis and Browning by Prebiotics and Postbiotics
Reynés, B., Palou, M., Rodríguez, A. M., & Palou, A. (2019) · Frontiers in Physiology · doi:10.3389/fphys.2018.01908 · Cited by 81
Reducing Cardiovascular Complications of Type 2 Diabetes by Targeting Multiple Risk Factors
Reasner, C. A. (2008) · Journal of Cardiovascular Pharmacology · doi:10.1097/fjc.0b013e31817ffe5a · Cited by 84
Metadata
- Authors
- Kawamata, Y., Fujii, R., Hosoya, M., Harada, M., Yoshida, H., Miwa, M., Fukusumi, S., Habata, Y., Itoh, T., Shintani, Y., Hinuma, S., Fujisawa, Y., & Fujino, M.
- Affiliations
- Takeda (Japan) (JP)
- Corresponding author
- Hinuma, Shuji
- Venue
- Journal of Biological Chemistry
- Publisher
- Elsevier BV
- Published
- 2003-03
- Volume
- 278
- Issue
- 11
- Pages
- 9435-9440
- ISSN
- 0021-9258 (ISSN-L)
- OpenAlex
- W2096418655
- Cited by
- 1,628
- References
- 27
- Citations by year
- 2026: 96 · 2025: 90 · 2024: 114 · 2023: 122 · 2022: 101 · 2021: 114 · 2020: 100 · 2019: 99 · 2018: 108 · 2017: 99 · 2016: 77 · 2015: 76 · 2014: 71 · 2013: 75 · 2012: 50
- FWCI
- 6.99
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- cc-by
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
- creativecommons.org/licenses/by/4.0/ (vor, 6433 d)
- Locations
- Journal of Biological Chemistry (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Oncology › Drug Transport and Resistance Mechanisms
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Receptor Mechanisms and Signaling
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Biochemistry › Cholesterol and Lipid Metabolism
- Keywords
- TGR5, G protein-coupled receptors, bile acids, cell surface receptors, receptor internalization, ERK MAP kinase, cAMP production, macrophages, monocytes, phagocytosis, cytokine production, lipopolysaccharide, THP-1 cells, alveolar macrophages
- MeSH terms
- Cyclic AMP, Amino Acid Sequence, Animals, Bile Acids and Salts, Cell Line, Cell Membrane, Dose-Response Relationship, Drug, Genetic Vectors, Cricetinae, Humans, Luminescent Proteins, Macrophages, Molecular Sequence Data, Phagocytosis, Protein Binding, Rabbits, Receptors, Cell Surface, Recombinant Fusion Proteins, RNA, Messenger, Time Factors, Tissue Distribution, Transfection, Cytokines, Guanosine 5'-O-(3-Thiotriphosphate), CHO Cells, GTP-Binding Proteins, Reverse Transcriptase Polymerase Chain Reaction, Mitogen-Activated Protein Kinases, MAP Kinase Signaling System, Receptors, G-Protein-Coupled, Green Fluorescent Proteins, Mice, Rats
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.